{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Hello everyone,\n",
    "\n",
    "this project is called \"machine learning for disambiguation of clinical trial scientist names\".\n",
    "\n",
    "We will be using the concept of \"namespace\", a namespace comprises all the scientist with the same last name and the same initial for the first name.\n",
    "\n",
    "We will be pairing clinical trials done by scientists whose names belong to a certain namespace to researches done by scientists whose names belong to the same namespace.\n",
    "\n",
    "After pairing them, we will asses if the scientist is the same or if she/he's not."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "First thing first, to get this jupyter notebook working, you will need to download all the clinical trials at this link : https://clinicaltrials.gov/AllPublicXML.zip\n",
    "\n",
    "After doing that, extract all the files in a folder called \"AllPublicXML\".\n",
    "\n",
    "Check to have a lot of folders named (as an example) \"NTC0000xxxx\" or with other numbers under the \"AllPublicXML\" folder, if so, fantastic, you will be able to run this.\n",
    "\n",
    "The next Cell contains a small test, if you have configured all correctly, you will be able to see the content of an XML file, we used 'NTC00270075' as an example, feel free to try with others if you want (remember, not all the numbers are valid ID)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<?xml version=\"1.0\" ?>\n",
      "<clinical_study>\n",
      "\t\n",
      "  \n",
      "\t<!-- This xml conforms to an XML Schema at:\n",
      "    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->\n",
      "\t\n",
      "  \n",
      "\t<required_header>\n",
      "\t\t\n",
      "    \n",
      "\t\t<download_date>ClinicalTrials.gov processed this data on May 29, 2019</download_date>\n",
      "\t\t\n",
      "    \n",
      "\t\t<link_text>Link to the current ClinicalTrials.gov record.</link_text>\n",
      "\t\t\n",
      "    \n",
      "\t\t<url>https://clinicaltrials.gov/show/NCT00270075</url>\n",
      "\t\t\n",
      "  \n",
      "\t</required_header>\n",
      "\t\n",
      "  \n",
      "\t<id_info>\n",
      "\t\t\n",
      "    \n",
      "\t\t<org_study_id>CR005896</org_study_id>\n",
      "\t\t\n",
      "    \n",
      "\t\t<nct_id>NCT00270075</nct_id>\n",
      "\t\t\n",
      "  \n",
      "\t</id_info>\n",
      "\t\n",
      "  \n",
      "\t<brief_title>A Study to Determine the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Not Anemic and Who Will be Undergoing Orthopedic or Heart and Blood Vessel Surgery</brief_title>\n",
      "\t\n",
      "  \n",
      "\t<official_title>Recombinant Human Erythropoietin (R-HuEPO) in Non-Anemic Patients Scheduled for Orthopedic or Cardiovascular Surgery, to Facilitate Presurgical Autologous Blood Donation (A Double-blind, Randomized, Dose Finding Study)</official_title>\n",
      "\t\n",
      "  \n",
      "\t<sponsors>\n",
      "\t\t\n",
      "    \n",
      "\t\t<lead_sponsor>\n",
      "\t\t\t\n",
      "      \n",
      "\t\t\t<agency>Johnson &amp; Johnson Pharmaceutical Research &amp; Development, L.L.C.</agency>\n",
      "\t\t\t\n",
      "      \n",
      "\t\t\t<agency_class>Industry</agency_class>\n",
      "\t\t\t\n",
      "    \n",
      "\t\t</lead_sponsor>\n",
      "\t\t\n",
      "  \n",
      "\t</sponsors>\n",
      "\t\n",
      "  \n",
      "\t<source>Johnson &amp; Johnson Pharmaceutical Research &amp; Development, L.L.C.</source>\n",
      "\t\n",
      "  \n",
      "\t<brief_summary>\n",
      "\t\t\n",
      "    \n",
      "\t\t<textblock>\n",
      "      The purpose of this study is to determine whether epoetin alfa will enable self-donation of\n",
      "      at least 4 units of blood during the 2-week period before surgery (which is a shorter period\n",
      "      of time than the conventional 3-week blood donation period before surgery) in patients who\n",
      "      are not anemic and who will be undergoing orthopedic or heart and blood vessel surgery.\n",
      "      Epoetin alfa is a genetically engineered protein that stimulates red blood cell production.\n",
      "    </textblock>\n",
      "\t\t\n",
      "  \n",
      "\t</brief_summary>\n",
      "\t\n",
      "  \n",
      "\t<detailed_description>\n",
      "\t\t\n",
      "    \n",
      "\t\t<textblock>\n",
      "      Patients undergoing orthopedic or heart and blood vessel surgery frequently require blood\n",
      "      transfusions both during and after the operation. Patients often have their own blood\n",
      "      collected for this purpose over a standard 3- to 4-week period before surgery. A large\n",
      "      percentage of patients are not able to pre-deposit their own blood for transfusion. For such\n",
      "      patients, an agent that can facilitate self-donation and reduce the need for transfusions\n",
      "      from others in less time than the conventional 3 weeks before surgery may improve the overall\n",
      "      safety of surgery. This is a randomized, double-blind, placebo-controlled, parallel group,\n",
      "      multicenter study to evaluate whether epoetin alfa will enable the self-deposit of at least 4\n",
      "      units of blood in the abbreviated presurgical time period of 2 weeks by patients who are not\n",
      "      anemic and who are undergoing orthopedic or heart and blood vessel surgery. The study\n",
      "      consists of a 7-day screening period when patients will be tested for eligibility for the\n",
      "      study, a 14-day treatment and blood collection period, and a follow-up evaluation period\n",
      "      beginning 1 day before surgery and continuing to a study termination visit performed at the\n",
      "      patient's discharge from the hospital after surgery. Eligible patients will be randomly\n",
      "      assigned to one of four treatment groups: epoetin alfa 300 units/kilogram (U/kg), epoetin\n",
      "      alfa 600 U/kg, placebo to match the volume of epoetin alfa 300 U/kg, or placebo to match the\n",
      "      volume of epoetin alfa 600 U/kg, given by injection into a vein. Twice as many patients will\n",
      "      receive treatment with epoetin alfa as will receive treatment with placebo. A total of 3\n",
      "      doses of study medication will be administered to each patient, one dose given on each of\n",
      "      Days 1, 4, and 7 of the study. Additionally, from Day 1 to Day 14 of the study, all patients\n",
      "      will receive 200 milligrams of iron and 5 milligrams of a folate supplement daily by mouth to\n",
      "      support red blood cell generation. On Day 1, before the first dose of study drug, one unit of\n",
      "      blood will be collected from each patient and stored for self-donated blood transfusion. An\n",
      "      additional unit of blood will be collected from each patient (before administration of study\n",
      "      drug) and stored for self-donated blood transfusion on each of Days 4, 7, 11, and 14, only if\n",
      "      the patient's hemoglobin level is &gt;11.0 g/dL; if a patient's hemoglobin level is &lt;=11.0 g/dL\n",
      "      on any of these days, no blood will be collected on that day, although study drug will be\n",
      "      given. A maximum of 5 units of blood will be collected from any patient. If sufficient units\n",
      "      for the planned surgery are not collected, preparations will be made for patients to receive\n",
      "      needed units of blood from donors. The study duration is 14 days, ending before surgery.\n",
      "      Safety evaluations will include laboratory tests, vital signs, and reporting of the incidence\n",
      "      of adverse events. Effectiveness will be evaluated by comparing the number of self-donated\n",
      "      units of blood collected within 2 weeks, and the change in hemoglobin level among the\n",
      "      different treatment groups from before the start of the study to the end of the study. The\n",
      "      study hypothesis is that in an abbreviated (2-week) period before surgery, epoetin alfa will\n",
      "      facilitate collection of at least 4 units of self-donated blood in patients who are not\n",
      "      anemic and who are undergoing orthopedic or heart and blood vessel surgery. Epoetin alfa 300\n",
      "      units/kilogram (U/kg), epoetin alfa 600 U/kg, placebo matching the volume of the 300 U/kg\n",
      "      dose, or placebo matching the volume of the 300 U/kg dose, by injection into a vein; given on\n",
      "      each of Days 1, 4, and 7 of the study.\n",
      "    </textblock>\n",
      "\t\t\n",
      "  \n",
      "\t</detailed_description>\n",
      "\t\n",
      "  \n",
      "\t<overall_status>Completed</overall_status>\n",
      "\t\n",
      "  \n",
      "\t<start_date>January 1990</start_date>\n",
      "\t\n",
      "  \n",
      "\t<completion_date type=\"Actual\">May 1992</completion_date>\n",
      "\t\n",
      "  \n",
      "\t<phase>Phase 2/Phase 3</phase>\n",
      "\t\n",
      "  \n",
      "\t<study_type>Interventional</study_type>\n",
      "\t\n",
      "  \n",
      "\t<has_expanded_access>No</has_expanded_access>\n",
      "\t\n",
      "  \n",
      "\t<study_design_info>\n",
      "\t\t\n",
      "    \n",
      "\t\t<allocation>Randomized</allocation>\n",
      "\t\t\n",
      "    \n",
      "\t\t<intervention_model>Parallel Assignment</intervention_model>\n",
      "\t\t\n",
      "    \n",
      "\t\t<primary_purpose>Treatment</primary_purpose>\n",
      "\t\t\n",
      "    \n",
      "\t\t<masking>Double</masking>\n",
      "\t\t\n",
      "  \n",
      "\t</study_design_info>\n",
      "\t\n",
      "  \n",
      "\t<primary_outcome>\n",
      "\t\t\n",
      "    \n",
      "\t\t<measure>Number of self-donated units of blood collected within 2 weeks; Change in hemoglobin level from before the start of the study to the end of the study</measure>\n",
      "\t\t\n",
      "  \n",
      "\t</primary_outcome>\n",
      "\t\n",
      "  \n",
      "\t<secondary_outcome>\n",
      "\t\t\n",
      "    \n",
      "\t\t<measure>Changes in safety parameters (laboratory tests, vital signs, physical examination, and adverse events) from before the study to the end of the study</measure>\n",
      "\t\t\n",
      "  \n",
      "\t</secondary_outcome>\n",
      "\t\n",
      "  \n",
      "\t<enrollment type=\"Actual\">80</enrollment>\n",
      "\t\n",
      "  \n",
      "\t<condition>Blood Transfusion</condition>\n",
      "\t\n",
      "  \n",
      "\t<condition>Blood Transfusion, Autologous</condition>\n",
      "\t\n",
      "  \n",
      "\t<condition>Orthopedic Procedures</condition>\n",
      "\t\n",
      "  \n",
      "\t<condition>Orthopedic Surgery</condition>\n",
      "\t\n",
      "  \n",
      "\t<condition>Cardiovascular Surgical Procedure</condition>\n",
      "\t\n",
      "  \n",
      "\t<intervention>\n",
      "\t\t\n",
      "    \n",
      "\t\t<intervention_type>Drug</intervention_type>\n",
      "\t\t\n",
      "    \n",
      "\t\t<intervention_name>epoetin alfa</intervention_name>\n",
      "\t\t\n",
      "  \n",
      "\t</intervention>\n",
      "\t\n",
      "  \n",
      "\t<eligibility>\n",
      "\t\t\n",
      "    \n",
      "\t\t<criteria>\n",
      "\t\t\t\n",
      "      \n",
      "\t\t\t<textblock>\n",
      "        Inclusion Criteria:\n",
      "\n",
      "          -  Patients scheduled for orthopedic or heart and blood vessel surgery\n",
      "\n",
      "          -  requirement of 3 or more units of blood\n",
      "\n",
      "          -  who are non-anemic (hemoglobin within normal range of 12.0 - 18.0 grams/deciliter)\n",
      "\n",
      "          -  having laboratory tests within normal ranges\n",
      "\n",
      "        Exclusion Criteria:\n",
      "\n",
      "          -  Patients with history of any primary blood disease\n",
      "\n",
      "          -  having signs and symptoms of significant disease/dysfunction, such as signs and\n",
      "             symptoms of significant heart and blood vessel disease (in patients undergoing\n",
      "             orthopedic surgery) or severe alteration in rhythm of the heartbeat, persistent brief\n",
      "             attacks of chest pain, or significant heart failure in which the heart is unable to\n",
      "             maintain adequate circulation of blood (in patients undergoing heart and blood vessel\n",
      "             surgery)\n",
      "\n",
      "          -  having uncontrolled high blood pressure or signs and symptoms of significant\n",
      "             dizziness, faintness, or lightheadedness which appear only on standing and are caused\n",
      "             by low blood pressure\n",
      "\n",
      "          -  who have received a blood transfusion within 1 month before the start of the study\n",
      "\n",
      "          -  having a body weight greater than 100 kilograms (approximately 220 pounds)\n",
      "      </textblock>\n",
      "\t\t\t\n",
      "    \n",
      "\t\t</criteria>\n",
      "\t\t\n",
      "    \n",
      "\t\t<gender>All</gender>\n",
      "\t\t\n",
      "    \n",
      "\t\t<minimum_age>18 Years</minimum_age>\n",
      "\t\t\n",
      "    \n",
      "\t\t<maximum_age>N/A</maximum_age>\n",
      "\t\t\n",
      "    \n",
      "\t\t<healthy_volunteers>No</healthy_volunteers>\n",
      "\t\t\n",
      "  \n",
      "\t</eligibility>\n",
      "\t\n",
      "  \n",
      "\t<overall_official>\n",
      "\t\t\n",
      "    \n",
      "\t\t<last_name>Johnson &amp; Johnson Pharmaceutical Research &amp; Development, L.L. C. Clinical Trial</last_name>\n",
      "\t\t\n",
      "    \n",
      "\t\t<role>Study Director</role>\n",
      "\t\t\n",
      "    \n",
      "\t\t<affiliation>Johnson &amp; Johnson Pharmaceutical Research &amp; Development, L.L.C.</affiliation>\n",
      "\t\t\n",
      "  \n",
      "\t</overall_official>\n",
      "\t\n",
      "  \n",
      "\t<link>\n",
      "\t\t\n",
      "    \n",
      "\t\t<url>http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_JNJ_6051&amp;studyid=678&amp;filename=CR005896_CSR.pdf</url>\n",
      "\t\t\n",
      "    \n",
      "\t\t<description>A study to determine the safety and effectiveness of epoetin alfa in facilitating self-donation of blood before surgery in patients who are not anemic and who are undergoing orthopedic or heart and blood vessel surgery</description>\n",
      "\t\t\n",
      "  \n",
      "\t</link>\n",
      "\t\n",
      "  \n",
      "\t<verification_date>February 2011</verification_date>\n",
      "\t\n",
      "  \n",
      "\t<study_first_submitted>December 22, 2005</study_first_submitted>\n",
      "\t\n",
      "  \n",
      "\t<study_first_submitted_qc>December 22, 2005</study_first_submitted_qc>\n",
      "\t\n",
      "  \n",
      "\t<study_first_posted type=\"Estimate\">December 26, 2005</study_first_posted>\n",
      "\t\n",
      "  \n",
      "\t<last_update_submitted>May 17, 2011</last_update_submitted>\n",
      "\t\n",
      "  \n",
      "\t<last_update_submitted_qc>May 17, 2011</last_update_submitted_qc>\n",
      "\t\n",
      "  \n",
      "\t<last_update_posted type=\"Estimate\">May 18, 2011</last_update_posted>\n",
      "\t\n",
      "  \n",
      "\t<keyword>epogen</keyword>\n",
      "\t\n",
      "  \n",
      "\t<keyword>erythropoietin</keyword>\n",
      "\t\n",
      "  \n",
      "\t<keyword>orthopedic procedures</keyword>\n",
      "\t\n",
      "  \n",
      "\t<keyword>orthopedic surgery</keyword>\n",
      "\t\n",
      "  \n",
      "\t<keyword>cardiovascular surgical procedures</keyword>\n",
      "\t\n",
      "  \n",
      "\t<keyword>Blood transfusion</keyword>\n",
      "\t\n",
      "  \n",
      "\t<keyword>epoetin alfa</keyword>\n",
      "\t\n",
      "  \n",
      "\t<intervention_browse>\n",
      "\t\t\n",
      "    \n",
      "\t\t<!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->\n",
      "\t\t\n",
      "    \n",
      "\t\t<mesh_term>Epoetin Alfa</mesh_term>\n",
      "\t\t\n",
      "  \n",
      "\t</intervention_browse>\n",
      "\t\n",
      "  \n",
      "\t<!-- Results have not yet been posted for this study                                          -->\n",
      "\t\n",
      "\n",
      "</clinical_study>\n",
      "\n"
     ]
    }
   ],
   "source": [
    "import xml.dom.minidom as xml_dom    # we need this library in order to extract the dom from an xml document\n",
    "\n",
    "# This function returns the location of a file, given the clinical trial ID or the file name\n",
    "def get_file_location(name):\n",
    "    inner_folder = name[:7] + 'xxxx'   # I get the name of the inner folder (e.g. NTC0000xxxx)\n",
    "    location = 'AllPublicXML\\\\' + inner_folder + '\\\\' + name   # I set the location\n",
    "    if(name[-4:] != '.xml'):\n",
    "        location += '.xml'    # If the input was the ID, we add .xml because the file name is identical to the ID\n",
    "    return location    # I return the file location\n",
    "    \n",
    "# This function allows us to get the dom of a file, specifying the file name or the ID of the clinical trial\n",
    "def xml_doc_string(name):\n",
    "    location = get_file_location(name)    # here we set the location of the file\n",
    "    try:\n",
    "        dom = xml_dom.parse(location)    # we parse the file using xml_dom\n",
    "    except:\n",
    "        return 'file not found'   # if I cannot find the file, I return this string instead\n",
    "    xml_dom_as_string = dom.toprettyxml()    # get the dom as a string\n",
    "    return xml_dom_as_string    # return the string\n",
    "\n",
    "# Let's test it, if it works, you have set up the folders correclty\n",
    "print(xml_doc_string('NCT00270075'))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Now that we have the folders in the right place, we proceed to create functions that will be able to find a specific field in the XML file."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'\\n      The purpose of this study is to determine whether epoetin alfa will enable self-donation of\\n      at least 4 units of blood during the 2-week period before surgery (which is a shorter period\\n      of time than the conventional 3-week blood donation period before surgery) in patients who\\n      are not anemic and who will be undergoing orthopedic or heart and blood vessel surgery.\\n      Epoetin alfa is a genetically engineered protein that stimulates red blood cell production.\\n    '"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# This function takes the ID/file name of the XML file and the name of the node to search and returns\n",
    "# all the nodes with the specified name\n",
    "def get_xml_node(ID, node_name):\n",
    "    location = get_file_location(ID)\n",
    "    try:\n",
    "        dom = xml_dom.parse(location)\n",
    "    except:\n",
    "        return 'file not found'\n",
    "    nodes = dom.getElementsByTagName(node_name)\n",
    "    return nodes\n",
    "    \n",
    "node = get_xml_node('NCT00270075', 'textblock')\n",
    "node[0].firstChild.nodeValue    #print the content of the first node found"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.\n",
      "Value of node:  <Element 'official_title' at 0x00000180E9018D18>\n"
     ]
    }
   ],
   "source": [
    "import xml.etree.ElementTree as ET\n",
    "\n",
    "# This recursive function is needed to go through all the hierarchy and get the node (no 'clinical_trial' tag needed)\n",
    "def recursive_node_search(root,hierarchy):\n",
    "    for child in root:\n",
    "        if(child.tag == hierarchy[0]):\n",
    "            if(len(hierarchy) == 1):\n",
    "                return child\n",
    "            return recursive_node_search(child, hierarchy[1:])\n",
    "\n",
    "# This function takes the ID/file name of the XML file and the hierarchy of the node to search and returns\n",
    "# the node with the specified name\n",
    "def get_xml_node_hierarchy(ID, node_hierarchy):\n",
    "    location = get_file_location(ID)\n",
    "    try:\n",
    "        dom = ET.parse(location)\n",
    "    except:\n",
    "        return 'file not found'\n",
    "    node = recursive_node_search(dom.getroot(),node_hierarchy)\n",
    "    return node\n",
    "    \n",
    "node = get_xml_node_hierarchy('NCT00270075', ['sponsors','lead_sponsor','agency'])\n",
    "print(node.text)\n",
    "# If the node doesn't exist, a None is returned\n",
    "node = get_xml_node_hierarchy('NCT00270075', ['sponsors','lead_sponsor','non_existent_node'])\n",
    "print(\"Value of node: \", node)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.\n",
      "Recombinant Human Erythropoietin (R-HuEPO) in Non-Anemic Patients Scheduled for Orthopedic or Cardiovascular Surgery, to Facilitate Presurgical Autologous Blood Donation (A Double-blind, Randomized, Dose Finding Study)\n"
     ]
    }
   ],
   "source": [
    "# This function can be used to get the dom and to do multiple things with it\n",
    "def get_xml_dom(ID):\n",
    "    location = get_file_location(ID)\n",
    "    try:\n",
    "        return ET.parse(location)\n",
    "    except:\n",
    "        return 'file not found'\n",
    "    \n",
    "root = get_xml_dom('NCT00270075').getroot()\n",
    "print(recursive_node_search(root,['sponsors','lead_sponsor','agency']).text)\n",
    "print(recursive_node_search(root,['official_title']).text)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
